PGHL.NS Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:59):

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements...

Stats
Tagesvolumen	4 362.00
Durchschnittsvolumen	21 402.00
Marktkapitalisierung	78.60B
EPS	INR0 ( 2024-02-05 )
Nächstes Ertragsdatum	( INR0 ) 2024-05-02
Last Dividend	INR45.00 ( 2023-02-13 )
Next Dividend	INR0 ( N/A )
P/E	34.66
ATR14	INR5.09 (0.11%)

Volumen Korrelation

Lang: -0.12 (neutral)

Kurz: -0.08 (neutral)

Signal:(49.312) Neutral

Procter & Gamble Health Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Procter & Gamble Health Korrelation - Währung/Rohstoff

0.63
( weak )

0.54
( weak )

0.78
( moderate )

0.72
( moderate )

0.35
( neutral )

-0.52
( weak negative )

Procter & Gamble Health Finanzdaten

Annual	2022
Umsatz:	INR12.30B
Bruttogewinn:	INR8.68B (70.57 %)
EPS:	INR138.24

FY	2022
Umsatz:	INR12.30B
Bruttogewinn:	INR8.68B (70.57 %)
EPS:	INR138.24

FY	2023
Umsatz:	INR0
Bruttogewinn:	INR0 (0.00 %)
EPS:	INR0

FY	2022
Umsatz:	INR10.92B
Bruttogewinn:	INR7.25B (66.38 %)
EPS:	INR116.00

Financial Reports:

No articles found.

Procter & Gamble Health Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR11.50 (N/A)	INR45.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Procter & Gamble Health Dividend Information - Dividend Junior

Dividend Sustainability Score: 7.44 - good (74.44%) | Divividend Growth Potential Score: 2.95 - Decrease likely (41.03%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR7.80	2003-05-12
Last Dividend	INR45.00	2023-02-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	23	--
Total Paid Out	INR1 058.30	--
Avg. Dividend % Per Year	0.95%	--
Score	2.67	--
Div. Sustainability Score	7.44
Div.Growth Potential Score	2.95
Div. Directional Score	5.20	--

Next Divdend (Est)
(2025-02-05)

INR0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

2.67

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR15.00	0.68%
2019	INR416.00	13.20%
2020	INR188.00	4.26%
2021	INR90.00	1.29%
2022	INR52.50	1.00%
2023	INR45.00	1.12%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TORNTPHARM.NS	Dividend Junior	2023-06-23	Annually	22	0.85%
PGHH.NS	Dividend Knight	2023-11-16	Semi-Annually	21	0.86%
JBMA.NS	Dividend Junior	2023-09-08	Annually	20	0.32%
DECCANCE.NS	Dividend Junior	2023-09-22	Annually	17	0.64%
SKFINDIA.NS	Dividend Junior	2023-06-28	Annually	22	0.93%
METROBRAND.NS	Dividend Junior	2023-08-31	Semi-Annually	3	0.18%
HAL.NS	Dividend Knight	2023-08-24	Semi-Annually	6	4.33%
BCG.NS	Ex Dividend Junior	2023-09-28	Sporadic	9	0.20%
PSB.NS	No Dividend Player	2023-07-04	Sporadic	14	0.77%
KCP.NS	Dividend Junior	2023-08-10	Annually	23	0.55%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.183	1.500	6.34	9.50	[0 - 0.5]
returnOnAssetsTTM	0.210	1.200	2.99	3.58	[0 - 0.3]
returnOnEquityTTM	0.298	1.500	7.80	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.35	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	2.50	0.800	0.0153	0.0122	[0.8 - 2.5]
cashRatioTTM	1.846	1.500	0.854	1.281	[0.2 - 2]
debtRatioTTM	0.0100	-1.500	9.83	-10.00	[0 - 0.6]
interestCoverageTTM	405.00	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 20]
debtEquityRatioTTM	0.0134	-1.500	9.95	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.648	1.000	2.54	2.54	[0.2 - 0.8]
operatingProfitMarginTTM	0.246	1.000	7.09	7.09	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	1.149	0.800	5.68	4.54	[0.5 - 2]
Total Score				7.44

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	34.68	1.000	6.60	0	[1 - 100]
returnOnEquityTTM	0.298	2.50	8.59	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
dividendYielPercentageTTM	5.28	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0	2.00	0	0	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	1.461	1.500	3.59	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0	1.000	-2.50	0	[0.1 - 0.5]
Total Score				2.95

Procter & Gamble Health

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemicals in India. It provides over-the-counter products, vitamins, minerals, and supplements. The company offers its products under the Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. Procter & Gamble Health Limited also exports its pharmaceutical products to Sri Lanka, Nepal, Myanmar, and Maldives. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.

Echtzeitaktualisierungen für Procter & Gamble Health [PGHL.NS]

Upcoming Earnings Alert

Procter & Gamble Health Dividend Information - Dividend Junior

Dividend Commentary

Top 10 dividend Companies for NSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)